Human medicines European public assessment report (EPAR): Revlimid, lenalidomide, Date of authorisation: 14/06/2007, Revision: 53, Status: Authorised

Submitted by Anonymous (not verified) on 10 July 2025 - 15:00

Human medicines European public assessment report (EPAR): Revlimid, lenalidomide, Date of authorisation: 14/06/2007, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR): Xbryk, denosumab, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 10 July 2025 - 14:55

Human medicines European public assessment report (EPAR): Xbryk, denosumab, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Temozolomide Sun, temozolomide, Date of authorisation: 13/07/2011, Revision: 21, Status: Authorised

Submitted by Anonymous (not verified) on 10 July 2025 - 13:48

Human medicines European public assessment report (EPAR): Temozolomide Sun, temozolomide, Date of authorisation: 13/07/2011, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Plegridy, peginterferon beta-1a, Date of authorisation: 18/07/2014, Revision: 26, Status: Authorised

Submitted by Anonymous (not verified) on 10 July 2025 - 13:43

Human medicines European public assessment report (EPAR): Plegridy, peginterferon beta-1a, Date of authorisation: 18/07/2014, Revision: 26, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness